# Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

> clinical trial · VERIFIED · 2026-06-24

Status: ACTIVE_NOT_RECRUITING · Sponsor: Alexion Pharmaceuticals, Inc. · Condition: Neuromyelitis Optica Spectrum Disorder

- Company: Alexion Pharmaceuticals, Inc.
- Sector: pharma
- Primary source: https://clinicaltrials.gov/study/NCT05346354

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.